Effects of Erythrodiol on the Antioxidant Response and Proteome of HepG2 Cells
Metadatos
Afficher la notice complèteAuteur
Peñas Fuentes, Juan Luis; Rufino Palomares, Eva; Pérez Jiménez, Amalia; Reyes Zurita, Fernando Jesús; Lupiáñez Cara, José AntonioEditorial
MDPI
Materia
Erythrodiol HepG2 Cytotoxicity ROS Antioxidant enzymes GSH NADPH Proteome
Date
2021-12-29Referencia bibliográfica
Peñas-Fuentes, JL... [et al.]. Effects of Erythrodiol on the Antioxidant Response and Proteome of HepG2 Cells. Antioxidants 2022, 11, 73. [https://doi.org/10.3390/antiox11010073]
Patrocinador
University of Jaén (Plan Propio de Investigación, grant number UJA2014/07/13); Junta de Andalucía (Plan Andaluz de Investigación, Junta de Andalucía, Spain), grant BIO-341Résumé
Erythrodiol (EO) is a pentacyclic triterpenic alcohol found in olive tree leaves and olive
oil, and it has important effects on the health properties and quality of olive oil. In this study, we
characterized the cytotoxic effects of EO on human hepatocarcinoma (HepG2) cells by studying
changes in cell viability, reactive oxygen species (ROS) production, antioxidant defense systems, and
the proteome. The results reveal that EO markedly decreased HepG2 cell viability without changing
ROS levels. The concentrations of glutathione and NADPH were significantly reduced, with selective
changes in the activity of several antioxidant enzymes: glutathione peroxidase, glutathione reductase,
glucose 6-phosphate dehydrogenase, and 6-phosphogluconate dehydrogenase. Proteomic data reveal
that EO led to the complete elimination or decreased abundance of 41 and 3 proteins, respectively,
and the abundance of 29 proteins increased. The results of functional enrichment analysis show that
important metabolic processes and the nuclear transport of mature mRNA were impaired, whereas
AMP biosynthesis and cell cycle G2/M phase transition were induced. The transcription factors and
miRNAs involved in this response were also identified. These potent antiproliferative effects make
EO a good candidate for the further analysis of its hepatic antitumor effects in in vivo studies.